Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
Lara A. Ray, Spencer Bujarski, Erica N. Grodin, et al.
The American Journal of Drug and Alcohol Abuse (2018) Vol. 45, Iss. 2, pp. 124-140
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders
Lara A. Ray, Lindsay R. Meredith, Brian D. Kiluk, et al.
JAMA Network Open (2020) Vol. 3, Iss. 6, pp. e208279-e208279
Open Access | Times Cited: 177
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis
Shari S. Rogal, Ada O. Youk, Hongwei Zhang, et al.
Hepatology (2019) Vol. 71, Iss. 6, pp. 2080-2092
Open Access | Times Cited: 160
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 110
Hazardous drinking and alcohol use disorders
James MacKillop, Roberta Agabio, Sarah W. Feldstein Ewing, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 93
Prevention, screening, and treatment for heavy drinking and alcohol use disorder
Justin Knox, Deborah S. Hasin, Farren R R Larson, et al.
The Lancet Psychiatry (2019) Vol. 6, Iss. 12, pp. 1054-1067
Open Access | Times Cited: 114
Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial
Erica N. Grodin, Spencer Bujarski, Brandon Towns, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 64
Technology‐Delivered Cognitive‐Behavioral Interventions for Alcohol Use: A Meta‐Analysis
Brian D. Kiluk, Lara A. Ray, Justin Walthers, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 11, pp. 2285-2295
Open Access | Times Cited: 64
Peer Support and Overdose Prevention Responses: A Systematic ‘State-of-the-Art’ Review
Fiona Mercer, Joanna Miler, Bernie Pauly, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 22, pp. 12073-12073
Open Access | Times Cited: 50
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
Sophie Köhne, Thomas Hillemacher, Alexander Glahn, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 219-232
Closed Access | Times Cited: 6
Understanding low treatment seeking rates for alcohol use disorder: A narrative review of the literature and opportunities for improvement
Alexandra Venegas, Suzanna Donato, Lindsay R. Meredith, et al.
The American Journal of Drug and Alcohol Abuse (2021) Vol. 47, Iss. 6, pp. 664-679
Open Access | Times Cited: 39
Alcohol Use
Joseph H. Donroe, E. Jennifer Edelman
Annals of Internal Medicine (2022) Vol. 175, Iss. 10, pp. ITC145-ITC160
Closed Access | Times Cited: 27
An evaluation of cognitive behavioral therapy for substance use disorders: A systematic review and application of the society of clinical psychology criteria for empirically supported treatments.
Cassandra L. Boness, Victoria R. Votaw, Frank J. Schwebel, et al.
Clinical Psychology Science and Practice (2023) Vol. 30, Iss. 2, pp. 129-142
Open Access | Times Cited: 15
The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action
Stephan C. Tap
Addiction Biology (2024) Vol. 29, Iss. 4
Open Access | Times Cited: 5
The future of translational research on alcohol use disorder
Lara A. Ray, Erica N. Grodin, Lorenzo Leggio, et al.
Addiction Biology (2020) Vol. 26, Iss. 2
Open Access | Times Cited: 35
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Malia A. Belnap, Kaitlin R. McManus, Erica N. Grodin, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 4, pp. 291-302
Open Access | Times Cited: 4
Neural cue reactivity and intrinsic functional connectivity in individuals with alcohol use disorder following treatment with topiramate or naltrexone
Warren Logge, Paul Haber, Tristan Hurzeler, et al.
Psychopharmacology (2025)
Open Access
Adolescent Alcohol Use in Sub-Saharan Africa: A Growing Public Health Concern That Merits Attention from Multiple Stakeholders
Brian Maila
(2025), pp. 293-337
Closed Access
Preventing relapse in alcohol disorder with EEG-neurofeedback as a neuromodulation technique: A review and new insights regarding its application
Clémence Dousset, Hendrik Kajosch, Anaïs Ingels, et al.
Addictive Behaviors (2020) Vol. 106, pp. 106391-106391
Open Access | Times Cited: 32
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder
Falk W. Lohoff
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 18
Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial
Erica N. Grodin, Steven J. Nieto, Lindsay R. Meredith, et al.
Addiction Biology (2022) Vol. 27, Iss. 4
Open Access | Times Cited: 17
Precision medicine in alcohol use disorder: Mapping etiologic and maintenance mechanisms to mechanisms of behavior change to improve patient outcomes.
Cassandra L. Boness, Katie Witkiewitz
Experimental and Clinical Psychopharmacology (2022) Vol. 31, Iss. 4, pp. 769-779
Open Access | Times Cited: 17
Alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis
Wheytnie Alexandre, Muhammad Haseeb, Olufunso Agbalajobi, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
HPA axis function in alcohol use disorder: A systematic review and meta-analysis
Neil Dunne, Jo‐Hanna Ivers
Addiction Neuroscience (2023) Vol. 8, pp. 100114-100114
Open Access | Times Cited: 10
Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities
Pratima Sharma, Akhil Shenoy, Hersh Shroff, et al.
Liver Transplantation (2024) Vol. 30, Iss. 8, pp. 848-861
Closed Access | Times Cited: 3
Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies
Fahd François Hilal, Jérôme Jeanblanc, Chloé Deschamps, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 5, pp. 525-561
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top